Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 3, 2013, Pages 662-666

  Partl, Richard ^a   Richtig, Erika ^a   Avian, Alexander ^a   Berghold, Andrea ^a   Kapp, Karin S ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN METASTASIS; CEREBRAL METASTASIS; CONFIDENCE INTERVAL; HAZARD RATIO; LACTATE DEHYDROGENASE; LOCAL RECURRENCE; LYMPH NODE METASTASIS; MALIGNANT MELANOMA; MEDIAN SURVIVAL; METASTATIC DISEASE; MULTI VARIATE ANALYSIS; MULTIVARIATE SURVIVAL ANALYSIS; OVERALL SURVIVAL; PERFORMANCE STATUS; PROGNOSTIC FACTORS; STEREOTACTIC RADIOSURGERY; UNIVARIATE ANALYSIS; WHOLE-BRAIN IRRADIATION; WHOLE-BRAIN RADIATION;

BODY FLUIDS; DERMATOLOGY; ONCOLOGY; RADIOTHERAPY; TUMORS;

PATHOLOGY;

LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; EXTRACEREBRAL METASTASIS; FEMALE; HUMAN; INTRACEREBRAL METASTASIS; KARNOFSKY PERFORMANCE STATUS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; STEREOTACTIC RADIOSURGERY; WHOLE BRAIN RADIATION THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; L-LACTATE DEHYDROGENASE; MALE; MELANOMA; MIDDLE AGED; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84873312080     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.06.009     Document Type: Article

References (11)

1. J.L. Chason, F.B. Walker, and J.W. Landers Metastatic carcinoma in the central nervous system and dorsal root ganglia. A retrospective autopsy study Cancer 57 1963 781 787
2. L. Gaspar, C. Scott, and M. Rotman Recursive partitioning analysis (RPA) of prognostic factors in three Radation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiation Oncol Biol Phys 37 1997 745 751
3. P.W. Sperduto, B. Berkley, and L.E. Gaspar A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database Int J Radiat Oncol Biol Phys 70 2008 510 514
4. P.W. Sperduto, S.T. Chao, and P.K. Sneed Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients Int J Radiat Oncol Biol Phys. 77 2010 655 661
5. J.S. Barnholtz-Sloan, A.E. Sloan, and F.G. Davis Incidence proportions of brain metastases in patients diagnosed (1973-2001) in the Metropolitan Detroit Cancer Surveillance System J Clin Oncol 22 2004 2865 2872
6. D.R. Budman, E. Camacho, and R.E. Wittes The current cause of death in patients with malignant melanoma Eur J Cancer 14 1978 327 330
7. K.M. Fife, M.H. Colman, and G.N. Stevens Determinants of outcome in melanoma patients with cerebral metastases J Clin Oncol 22 2004 1293 1300
8. F. Lagerwaard, P. Levendag, and P. Nowak Identification of prognostic factors in patients with brain metastases: a review of 1292 patients Int J Radiat Oncol Biol Phys 43 1999 795 803
9. M. Staudt, K. Lasithiotakis, and U. Leiter Determinats of survival in patients with brain metastases from cutaneous melanoma Br J Cancer 102 2010 1213 1218
10. C. Nieder, K. Marienhagen, and H. Geinitz Can current prognostic scores reliably guide treatment decisions in patients with brain metastases form malignant melanoma? J Can Res Ther 7 2011 47 51
11. T.K. Eigentler, A. Figl, and D. Krex Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma Cancer 117 2011 1697 1703